Efficacy and safety of first-line immune checkpoint inhibitor–based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.

Detalles Bibliográficos
Publicado en:Urologic Oncology Vol. 44; no. 9; pp. 451 - 460
Autores principales: Takahashi, Hidetsugu, Fukuokaya, Wataru, Yanagisawa, Takafumi, Okamoto, Maria, Urabe, Fumihiko, Mori, Keiichiro, Nishimura, Shingo, Maenosono, Ryoichi, Toyoda, Shingo, Nukaya, Takuhisa, Morinaka, Hirofumi, Tamura, Keita, Araki, Motoo, Azuma, Haruhito, Fujita, Kazutoshi, Takahara, Kiyoshi, Komura, Kazumasa, Inamoto, Teruo, Kimura, Takahiro
Formato: Journal Article
Publicado: Elsevier B.V. Sep2026
Acceso en línea:Ver este registro en EBSCOhost